Hetlioz

Active Ingredient(s): Tasimelteon
FDA Approved: * January 31, 2014
Pharm Company: * VANDA PHARMACEUTICALS INC
Category: Sleep Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Hetlioz Overview

Tasimelteon (trade name Hetlioz) is a drug approved by the U.S. Food and Drug Administration (FDA)[2] in January 2014 for the treatment of non-24-hour sleep–wake disorder (also called non-24, N24 and N24HSWD).[3] In June 2014, the European Medicines Agency accepted an EU filing application for tasimelteon[4] and in July 2015, the drug was approved in Europe for the treatment of non-24-hour sleep-wake rhythm disorder in totally blind adults...

Read more Hetlioz Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tasimelteon

Recent Hetlioz Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Hetlioz: (1 result)

Sorted by National Drug Code

• 43068-220 Hetlioz 20 mg Oral Capsule by Vanda Pharmaceuticals Inc.

Other drugs which contain Tasimelteon or a similar ingredient: (1 result)

• TASIMELTEON